| Literature DB >> 28110810 |
Ravi Ranjan1, Shubhi Pandey1, Arun K Shukla2.
Abstract
Kappa opioid receptor (κ-OR) agonists are promising therapeutic candidates for pain and itch; however, they also exhibit the adverse effects of sedation and dysphoria. A recent study has demonstrated that a G protein-biased agonist for κ-OR provides effective pain and itch relief without causing sedation or dysphoria, in animal models.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28110810 DOI: 10.1016/j.tem.2017.01.001
Source DB: PubMed Journal: Trends Endocrinol Metab ISSN: 1043-2760 Impact factor: 12.015